---
category: news
title: "Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid"
excerpt: "Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability"
publishedDateTime: 2023-04-26T22:57:00Z
originalUrl: "https://www.prnewswire.co.uk/news-releases/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-301808935.html"
webUrl: "https://www.prnewswire.co.uk/news-releases/telix-accelerates-artificial-intelligence-ai-development-program-with-acquisition-of-dedicaid-301808935.html"
type: article

provider:
  name: PR Newswire
  domain: prnewswire.co.uk

topics:
  - Machine Learning
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?p=facebook"
    width: 629
    height: 329
    isCached: true

secured: "IsGqNggtB1ycALupWok1b5M6zy9v0/REokBrjjfHdVmZ4BJc+WQwt0Q4ps6zgysB9tV+r/1Qp1Oixyh0LE3xB2L3dHa96QGqZyvzomvmGV0HFK56K0uxOHJF7v+GTVAawLb7xc5ZcTms5EvKKeA5oNu+bNyEUFjPAvYtGvVe3H4ZyCe5EOe9P5n85mOEK502piNlFygeKgjgKfF3XRuai9SeFFydhRc0Xndk5AcM30aI0znB1dQiZsy50tn9GksimqYn98/DqQGsU1H4JjzN5GMr2n/+2XycRaa0wH5iM2Txnw9QhKcW+xn7amo7bOTkhr1XZGtP2E25ItRX7qMuNLTiik4akPuhNYU4GfRYGxQ=;8uzZUYIiYbkYfxCS572AgQ=="
---

